National Research Corporation (NRC)
NASDAQ: NRC · Real-Time Price · USD
15.61
-0.85 (-5.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
National Research Market Cap
National Research has a market cap or net worth of $360.33 million as of February 21, 2025. Its market cap has decreased by -60.93% in one year.
Market Cap
360.33M
Enterprise Value
419.69M
1-Year Change
-60.93%
Ranking
Category
Stock Price
$15.61
Market Cap Chart
Since December 1, 1998, National Research's market cap has increased from $43.70M to $360.33M, an increase of 724.55%. That is a compound annual growth rate of 8.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 366.50M | -11.49% |
Dec 31, 2024 | 414.10M | -57.38% |
Dec 29, 2023 | 971.50M | 5.48% |
Dec 30, 2022 | 921.00M | -12.83% |
Dec 31, 2021 | 1.06B | -2.32% |
Dec 31, 2020 | 1.08B | -34.17% |
Dec 31, 2019 | 1.64B | 73.99% |
Dec 31, 2018 | 944.40M | -32.45% |
Dec 29, 2017 | 1.40B | 33.39% |
Dec 30, 2016 | 1.05B | 36.40% |
Dec 31, 2015 | 768.40M | 20.06% |
Dec 31, 2014 | 640.00M | -26.24% |
Dec 31, 2013 | 867.70M | 133.57% |
Dec 31, 2012 | 371.50M | 42.34% |
Dec 30, 2011 | 261.00M | 14.32% |
Dec 31, 2010 | 228.30M | 65.55% |
Dec 31, 2009 | 137.90M | -28.88% |
Dec 31, 2008 | 193.90M | 3.58% |
Dec 31, 2007 | 187.20M | 19.69% |
Dec 29, 2006 | 156.40M | 28.83% |
Dec 30, 2005 | 121.40M | 4.93% |
Dec 31, 2004 | 115.70M | -1.78% |
Dec 31, 2003 | 117.80M | 72.73% |
Dec 31, 2002 | 68.20M | 54.30% |
Dec 31, 2001 | 44.20M | 57.30% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.21B |
UnitedHealth Group | 462.37B |
Johnson & Johnson | 384.45B |
Novo Nordisk | 370.84B |
AbbVie | 354.62B |
Abbott Laboratories | 230.98B |
AstraZeneca | 227.07B |
Merck & Co. | 221.80B |